Trailblazing the Oncology and Palliative Care Fellowship Experience and Finding Your Niche: Richa Thakur, MD, and Nida Khan, MD
In this Oncology Data Advisor® Fellows Forum interview, Richa Thakur, MD, Hematology/Oncology Fellow at Northwell Health, speaks with Nida Khan, MD, a third-year Internal Medicine Resident who is beginning a joint Medical Oncology and Palliative Care Fellowship this July. Dr. Khan discusses the unique opportunities provided by this new type of fellowship, her passions for palliative care and global health, and advice for navigating the fellowship application process to find your niche in the program that is the best fit for you.
In May 2023, the FDA granted approval to epcoritamab, a CD3-redirecting, CD20-targeting bispecific antibody, for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma. Following the approval, Oncology Data Advisor® spoke with Dr. Reid Merryman, an Attending Physician at Dana-Farber Cancer Institute and one of the investigators of the EPCORE NHL-1 trial, on which the approval was based, to learn more about the efficacy and safety of epcoritamab and its burgeoning role in the treatment of relapsed/refractory DLBCL.
At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® had the privilege of interviewing many distinguished physician, nurse, pharmacist, pathologist, and patient advocate speakers about their work and research. This playlist features video and podcast conversations on topics including shared decision making in renal cell carcinoma, nursing research regarding digital health for cancer survivors, social determinants of health in genetic testing for triple-negative breast cancer, an exclusive conversation with OncData's Editor in Chief, Dr. Thomas Abrams, and much more!
Additional Advances in PI3K Inhibitor Research and Clinical Trials: Staying Ahead of Hyperglycemia and Rash Management With Janie Metsker, RN, BSN, CN-BN
Phosphatidylinositol-3-kinase (PI3K) inhibitors are effective treatment for patients with breast cancer but can be associated with significant hyperglycemia and rash. In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Janie Metsker, RN, BSN, CN-BN, Clinical Coordinator at St. Luke's Koontz Center for Advanced Breast Cancer, shares updated strategies for managing these toxicities in order to provide the best outcomes for patients with breast cancer receiving PI3K inhibitors.
This year's Oncology Nursing Society (ONS) Congress featured numerous thought-provoking and motivating presentations from experts in the field of oncology nursing. Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center and Editorial Board Member of Oncology Data Advisor®, stopped by in between presentations to share the most inspiring t...
Palliative Care for Oncologists: the Value of Integrated Palliative Care Training During Fellowship With Richa Thakur, MD
In this Oncology Data Advisor® Fellows Forum Interview, Dr. Richa Thakur, Hematology/Oncology (Heme/Onc) Fellow at Northwell Health, outlines the need for palliative care education in the oncology setting and shares valuable resources for fellows who are interested in expanding their knowledge of palliative care and hospice to better serve their patients.
See, Hear, Feel: Exploring Cognitive Psychology and Emotional Intelligence in Medicine With Christine Ko, MD
In this interview, Oncology Data Advisor® is joined by Dr. Christine Ko, Professor of Dermatology and Pathology at Yale University and host of the See, Hear, Feel podcast. Dr. Ko shares her passion for incorporating cognitive psychology and emotional intelligence into medical practice and explains how doing so can enhance patient encounters and care.
At the 48th Annual Oncology Nursing Society (ONS) Congress, Dr. Megan Mullins, an Assistant Professor at the University of Texas (UT) Southwestern Cancer Center, gave a presentation on improving cancer survivorship for sexual and gender minorities. In this follow-up interview, she shares the ongoing efforts into improving cancer survivorship care for these populations, as well as advice and resources for clinicians for creating welcoming spaces for LGBTQ+ cancer patients and survivors.
In this interview from the Oncology Nursing Society (ONS) 2023 Congress, Oncology Data Advisor speaks with Lauren Ghazal, PhD, FNP-BC, a Family Nurse Practitioner and Post-Doctoral Research Fellow at the University of Michigan. Dr. Ghazal was honored at ONS Congress as a recipient of the 2023 Mara Mogensen Flaherty Memorial Lectureship Award to discuss "Current Challenges: Nursing Sustainability" along with fellow recipients Suzanne Carroll, RN, MS, AOCN®; Amy E. Rettig, DNP, MALM, MSN, BSN, RN ACNS-BC, PMHNP-BC; and 2000 Mara Mogensen Flaherty Memorial Lectureship Award recipient Debi Boyle, MSN, RN, AOCNS®,FAAN, serving as moderator. In this interview, Dr. Ghazal highlights her inspiring work and research investigating nursing sustainability and cancer survivorship for adolescents and young adults, and shares how to encourage more individuals to pursue a fulfilling career in nursing and research.
Igniting a Passion for Oncology Nursing With CURE Extraordinary Healer® Award Winner Abbey Kaler, MS, APRN, FNP-C
The 2023 winner of the CURE Extraordinary Healer® Award, announced at the recent Oncology Nursing Society (ONS) Congress in San Antonio, Texas, is Abbey Kaler, MS, APRN, FNP-C, Advanced Practice Registered Nurse in the Advanced Breast Cancer Program at the University of Texas MD Anderson Cancer Center. After the excitement of her win, Ms. Kaler sat down with Oncology Data Advisor to reflect on her passion for oncology nursing and for being able to connect with patients and help them through their journeys.
Validating Oncology Nursing Knowledge and Experience Through ONCC Certification With Tony Ellis, MSEd, CAE, ICE-CCP
Recently, the Oncology Nursing Certification Corporation (ONCC) unveiled its new logo, which embraces the diversity and the passion behind oncology nursing. In this interview, Tony Ellis, MSEd, CAE, ICE-CCP, the Executive Director of ONCC, shares the features of their recently rebranded website and the benefits of obtaining ONCC certification, as well as steps and tips for nurses who are interested in becoming certified.
Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Sunil Iyer, Chief Hematology/Oncology Fellow at the University of Miami, Florida, discusses his leukemia research, exciting new treatment directions, and what t...
Introducing the Oncology Data Advisor® Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows With Samuel Kareff, MD, MPH
Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Samuel Kareff, Chief Hematology/Oncology Fellow at the University of Miami's Sylvester Cancer Center, shares the educational topics that he is looking forward to sharing his insights on as a Fellows Forum member, including tips for fellowship application, specialty pros and cons, research advances, and collaborations with policymakers and patient advocacy groups.
Driving Health Care Accessibility Through Acute Myeloid Leukemia Research: National Minority Health Month With Ian Bouligny, MD
In this interview for National Minority Health Month, Oncology Data Advisor speaks with Dr. Ian Bouligny, a third-year Hematology/Oncology Fellow at Virginia Commonwealth University (VCU) Massey Cancer Center. Dr. Bouligny shares updates on his research regarding health care barriers faced by patients of minority populations with acute myeloid leukemia (AML) and suggests questions that clinicians can ask their patients to ensure proper treatment support and accessibility.
Piloting Melanoma Research and Local Cancer Care: An Oncology Data Advisor® Editorial Board Spotlight Interview With Richard Carvajal, MD
This interview is the first in a new series spotlighting the Oncology Data Advisor® Editorial Board, featuring Dr. Richard Carvajal, Director of Medical Oncology at Northwell Health Cancer Institute. Dr. Carvajal tells the story of how he became a melanoma researcher and shares his passions for developing targeted therapies for unique clinical subsets of melanoma and for providing high-quality cancer care for patients in their own neighborhoods.
Advocating for Equitable Care in Multiple Myeloma: National Minority Health Month With Shakira Grant, MBBS
In honor of National Minority Health Month, Dr. Shakira Grant, Assistant Professor at the University of North Carolina at Chapel Hill, sat down with Oncology Data Advisor to talk about her research surrounding racial disparities faced by patients with multiple myeloma. Dr. Grant outlines the existing barriers to equitable health care and shares valuable advice on steps that oncology clinicians can take to make health care more accessible for their patients of minority populations.
At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclide Therapy (FACT-RNT), a novel patient-reported outcomes (PRO) measure for patients with prostate cancer. In this follow-up interview, Dr. Gudenkauf shares more about how the measure was developed, its importance for capturing the patient experience, and its future implementation into both clinical practice and trials.
Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval." In this interview with Onc...
Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD
Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer (NSCLC). With nu...
Rare Disease Day With Thomas Abrams, MD; Maria Badillo, MSN, RN, OCN®, CCRP; and Ulka Vaishampayan, MD
In honor of Rare Disease Day on February 28, the Oncology Data Advisor Editorial Board held a live panel discussion that featured updates on rare gastrointestinal cancers from Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School; perspectives on nursing management of mantle cell lymphoma from Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center; and updates on rare genitourinary cancers from Dr. Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center.